RUNX inhibitor suppresses graft‐versus‐host disease through targeting RUNX‐NFATC2 axis

Patients with refractory graft‐versus‐host disease (GVHD) have a dismal prognosis. Therefore, novel therapeutic targets are still needed to be identified. Runt‐related transcriptional factor (RUNX) family transcription factors are essential transcription factors that mediate the essential roles in e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Hirohito, Masuda, Tatsuya, Noura, Mina, Furuichi, Kana, Matsuo, Hidemasa, Hirata, Masahiro, Kataoka, Tatsuki R., Hiramatsu, Hidefumi, Yasumi, Takahiro, Nakahata, Tatsutoshi, Imai, Yoichi, Takita, Junko, Adachi, Souichi, Sugiyama, Hiroshi, Kamikubo, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Haematologic Malignancy ‐ Cellular Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175814/
https://www.ncbi.nlm.nih.gov/pubmed/35844683
http://dx.doi.org/10.1002/jha2.230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175814/
https://www.ncbi.nlm.nih.gov/pubmed/35844683
http://dx.doi.org/10.1002/jha2.230

Ejemplares similares